Navigation Links
Genesis Biopharma's Scientific and Medical Advisory Board Welcomes Dr. Steven A. Rosenberg, Chief of the Surgery Branch at the NCI
Date:11/17/2011

LOS ANGELES, Nov. 17, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTCBB: GNBP), a biotechnology company developing targeted cancer immunotherapies, today announced that Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch at the National Cancer Institute, has joined the Company's Scientific and Medical Advisory Board.  Dr. Rosenberg also is Professor of Surgery at the Uniformed Services University of Health Sciences and at the George Washington University School of Medicine and Health Sciences, both in Washington D.C.  

"We are honored to have Dr. Rosenberg serve on our Scientific and Medical Advisory Board.  A leading authority on immunology and cancer, Dr. Rosenberg pioneered adoptive cell therapy using autologous tumor infiltrating lymphocytes (TILs) to successfully treat patients with metastatic melanoma," stated Anthony J. Cataldo, Chairman and Chief Executive Oficer of Genesis Biopharma.  Genesis Biopharma recently licensed rights to certain intellectual property relating to the use of adoptive cell therapy using autologous TILs for the treatment of metastatic melanoma, ovarian, breast and colorectal cancers from the National Institutes of Health.  "As the inventor of this therapy, Dr. Rosenberg will be an invaluable asset to Genesis Biopharma as we advance the clinical development for Contego™, our ready-to-infuse adoptive cell therapy using TILs, to treat Stage IV metastatic melanoma," added Mr. Cataldo.

Dr. Rosenberg has pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. He has also pioneered the development of gene therapy, and was first to successfully insert foreign genes into humans and to conduct clinical studies of the gene therapy of cancer.

Dr. Rosenberg's work in tumor immunology was recently highlighted in the July issue of Oncology Times in an article titled, "'/>"/>

SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Triple Analysis: Prostate Cancer, Angiogenesis and Peptides
2. ThermoGenesis Corp. to Announce First Quarter Fiscal 2012 Results on November 10, 2011
3. Genesis Biopharma Signs Worldwide License Agreement with the NIH for Adoptive Cell Therapy to Treat a Variety of Cancers
4. Efficacy Data from Phase III VELOUR Trial in Colorectal Cancer to be Presented at Angiogenesis Foundations 2011 M. Judah Folkman International Conference in Cambridge, Mass.
5. Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise
6. ThermoGenesis Reports Fourth Quarter and Year End 2011 Results; Annual Net Loss Reduced by More Than 50 Percent
7. ThermoGenesis Presentation at Rodman & Renshaw Conference
8. Genesis Biopharma Announces Letter to Shareholders Posted to Website
9. ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao
10. Mummy News: Genesis Medical Imaging Mobile CT Scan Unit Helps Chicagos Field Museum Discover Ancient Secrets
11. Genesis Biopharma to Hold Business Update Conference Call on June 29
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... N.J. , July 30, 2015 Eisai ... in the United States , European ... FDA, EMA and MHLW, respectively) for eribulin, for the ... who have received prior chemotherapy for advanced or metastatic ... on data from a pivotal global Phase 3 clinical ...
(Date:7/30/2015)... , July 30, 2015 Takeda Pharmaceutical ... study to fulfill the post-marketing commitment and submissions ... Pan European Multi-Database Bladder Cancer Risk Characterization Study ... cohort study, conducted in four European countries, for ... up to 10 years of follow-up. Findings demonstrate ...
(Date:7/30/2015)... , July 30, 2015  Big Cloud Analytics, ... analytics technology, announces it is working with Intel ... for the new Lockheed Martin Healthcare Technology Alliance. ... health information technology providers, medical technology companies and ... and innovation to improve care in rapidly evolving ...
Breaking Medicine Technology:Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 2Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 3
... ... Reportlinker.com announces that a new market research report ... Markets for Breast Biopsy Devices 2009 , ... markets for breast biopsy devices includes the spring ...
... , NATICK, Mass. and LONDON, Nov. ... ) today announced that it has received 510(k) clearance ... CE Mark approval to market its WallFlex® Fully Covered ... (obstructions) caused by tumors in patients with resectable or ...
Cached Medicine Technology:Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... As ... programs, the activity of recruiting patients becomes a serious challenge. Because of growing competition, ... program to patients within the local community. , The team at Wound ...
(Date:7/30/2015)... Angeles, CA (PRWEB) , ... July 30, 2015 , ... The connection between a healthy ... and women. The loss of a full head of hair can have a devastating ... how a person is perceived in the work place, the consequences of hair loss are ...
(Date:7/30/2015)... ... July 30, 2015 , ... Eyepartner is proud to ... San Diego, California’s Gaslamp Quarter Plaza for five years this September. , The ... the area for any suspicious activity. These cameras are in place to provide ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... into one of the largest, family-owned low cost service and repair companies. For ... applications, as well as growing their company to meet the demands of the ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... “Beachside Nursing Center,” to announce its position as one of Medicare’s top-rated ... and staff members support the CMS rating system, which monitors health inspections, ...
Breaking Medicine News(10 mins):Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4Health News:New Study Shows the Link between Hair Restoration and Healthy Self-Image 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 3Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3Health News:Beachside Nursing Center Releases New Video 2
... diseases, bringing in hope where ... there is none!, ... resigned to a life of pain with Rheumatoid Arthritis is healthy,and normal ... my,Good Shepherd, Jesus and His own good shepherd, Dr. Omar, have rescued ...
... DCGN ) today announced that it will host ... the Lazard Capital Markets 4th Annual,Healthcare Conference., The ... Tuesday, November,27 at the Palace Hotel, New York City. ... deCODE,s website, http://www.decode.com, and those,interested in listening ...
... Contaminated water could boost child,s cancer risk, study finds ... women exposed to arsenic-contaminated water during pregnancy have gene ... diseases later in life, a Massachusetts Institute of Technology ... work is the first documentation of widespread genetic ...
... AIDS Treatment Provision on World AIDS ... ... to an,increasing need for more effective AIDS treatments in India and recent,high-profile ... Organization (NACO) and Health Minister A.,Ramadoss will announce the rollout of lifesaving ...
... individual has on receiving his paycheque depend critically on ... comes from an experiment conducted by economists and brain ... subjects in pairs, asking them to perform a simple ... tomographs, the researchers examined the volunteers, brain activity throughout ...
... also encourages midday sleepiness, experts say, , , THURSDAY, Nov. ... heads after the Thanksgiving feast aren,t rare, and experts ... during the holiday. , It may have to do ... in tryptophan -- a chemical known to promote sleepiness, ...
Cached Medicine News:Health News:Stem Cells- Dr. Omar Gonzalez' Therapy for all Ills! 2Health News:NACO Bows to Activists' Pressure on AIDS Treatment in India, Says AHF 2Health News:NACO Bows to Activists' Pressure on AIDS Treatment in India, Says AHF 3Health News:Money motivates -- especially when your colleague gets less 2Health News:Money motivates -- especially when your colleague gets less 3Health News:There's More Than Turkey Behind Holiday Yawns 2
... No need to add individual components ... range of trauma indications. Made of an ... than conventional fixators, only much lighter. This ... apply, and more comfortable for the patient. ...
... an X-ray contrast medium for ... for: angiography, urography, phlebography and ... of the basal cisterns, following ... cholangio (pancreato) graphy (ERC(P)), herniography, ...
... (gadobenate dimeglumine) is a paramagnetic MRI contrast ... with gadobenate, a chelating agent that forms ... godolinium ion. It is salified with meglumine ... with all the physico-chemical features typical of ...
... ferumoxides) is Advanced Magnetics' contrast agent for use ... It is the first organ-specific MRI contrast agent ... function, the agent is taken up by macrophages ... in most tumors. The liver is a principal ...
Medicine Products: